| Alyssa L Fuggiti, CCC-SLP/L | |
|
1870 W Winchester Rd, Suite 203, Libertyville, IL 60048-5358 | |
| (847) 816-7200 | |
| (847) 816-7210 |
| Full Name | Alyssa L Fuggiti |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1870 W Winchester Rd, Libertyville, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013271774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.011095 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa L Fuggiti, CCC-SLP/L Po Box 7635, Libertyville, IL 60048-7635 Ph: () - | Alyssa L Fuggiti, CCC-SLP/L 1870 W Winchester Rd, Suite 203, Libertyville, IL 60048-5358 Ph: (847) 816-7200 |
News Archive
The Consumer Healthcare Products Association (CHPA) today applauded Ohio Governor John Kasich for signing into law House Bill 334, an anti-methamphetamine bill authored by Representative Terry Johnson (R-Portsmouth) and Representative Danny Bupb (R-West Union). With the new law, Ohio now becomes the 25th state to adopt real-time, stop-sale technology known as the National Precursor Log Exchange (NPLEx).
If racial and ethnic disparities in breast cancer exist, they are not due to differences in the use of imaging to assess the extent of tumors before surgery, according to new findings that will be presented by Fox Chase Cancer Center researchers at the 2012 Annual Meeting of the American Society of Clinical Oncology on Monday, June 4.
New research uncovers how a sticky protein called fibronectin promotes the activity of estrogen in breast cancer cells.
Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent's Comprehensive Cancer Center in New York.
Janssen Pharmaceuticals, Inc. announced today the acquisition of the investigational compound GSK2336805, an NS5a replication complex inhibitor in Phase 2 development for the treatment of chronic hepatitis C, from an affiliate of GlaxoSmithKline plc.
› Verified 6 days ago
Elizabeth Anne Day, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 S Milwaukee Ave, Suite220, Libertyville, IL 60048 Phone: 847-918-7947 Fax: 847-918-9622 | |
Cynthia Bryant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1860 W Winchester Rd Ste 108, Libertyville, IL 60048 Phone: 847-842-0597 | |
Andrea Rene Dell'aquila, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1288 Briarwood Ln, Libertyville, IL 60048 Phone: 219-218-8232 | |
Kylie Dyer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 854 Technology Way, Libertyville, IL 60048 Phone: 847-816-7200 | |
Margot Greenwald, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1870 W Winchester Rd, Suite 203, Libertyville, IL 60048 Phone: 847-816-7200 Fax: 847-816-7210 | |
Amy Warrington, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 854 Technology Way, Libertyville, IL 60048 Phone: 847-816-7200 |